Who we are
Leadership

Leadership

Our team is composed of experts with an unparalleled knowledge of science, technology, and medicine. Their immense depth of experience is ideally suited to the quest to reduce the burden of infectious disease around the globe.

Executive leadershipBoard of directors
John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
John C. Jacobs full biography
Rick Crowley
Rick Crowley
Executive Vice President,
Chief Operations Officer
Rick Crowley full biography
Filip Dubovsky, MD MPH
Filip Dubovsky, MD MPH
President,
Research and Development
Filip Dubovsky, MD MPH full biography
John A. Herrmann III
John A. Herrmann III
Executive Vice President,
Chief Legal Officer
John A. Herrmann III full biography
Jim Kelly
Jim Kelly
Executive Vice President,
Chief Financial Officer and
Treasurer
Jim Kelly full biography
Troy Morgan, JD
Troy Morgan, JD
Senior Vice President,
Chief Compliance Officer
Troy Morgan, JD full biography
Elaine O’Hara
Elaine O’Hara
Executive Vice President,
Chief Strategy Officer
Elaine O’Hara full biography
Silvia Taylor
Silvia Taylor
Executive Vice President,
Chief Corporate Affairs and Advocacy Officer
Silvia Taylor full biography
John J. Trizzino
John J. Trizzino
Executive Vice President,
Chief Commercial Officer and Chief Business Officer
John J. Trizzino full biography
Ian Watkins
Ian Watkins
Executive Vice President,
Chief Human Resources Officer
Ian Watkins full biography
John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
John C. Jacobs full biography
James F. Young, PhD
James F. Young, PhD
Chairman of the
Board of Directors
James F. Young, PhD full biography
Gregg Alton
Gregg Alton
Director
Gregg Alton full biography
Richard Douglas, PhD
Richard Douglas, PhD
Director
Richard Douglas, PhD full biography
Rachel King
Rachel King
Director
Rachel King full biography
Margaret G. McGlynn, R. Ph.
Margaret G. McGlynn, R. Ph.
Director
Margaret G. McGlynn, R. Ph. full biography
David Mott
David Mott
Director
David Mott full biography
Rick Rodgers, MBA
Rick Rodgers, MBA
Director
Rick Rodgers, MBA full biography

Corporate governance

Novavax’ Compliance program

Annual Declaration Clause for California (June 2023)

Novavax is committed to establishing and maintaining an effective compliance program that promotes conducting business activities in accordance with applicable laws, rules, and regulations, with the highest ethical standards in its interactions with all medical and health professionals and organizations. Novavax’ compliance program is designed to prevent, detect, and respond to potential instances of non-compliance.

Novavax Inc. declares that, to the best of our knowledge and understanding of statutory requirements, we have established a Comprehensive Compliance Program (CCP) that is in compliance with the Cal. Health & Safety Code §§ 119400-119402.

To obtain a written copy of our Code of Conduct or a written declaration of compliance, please contact 844-612-0252.

Careers

Build your future with us

Explore opportunities

Investors

Annual reports, events, and more

Visit the investors hub

Science & Technology

Our pipeline—creating tomorrow's vaccine today

Explore our pipeline